Phytochemical Analysis and Hypoglycaemic Activity of the Methanol Stem Bark Extract of Tabernaemontana pachysiphon Stapf (Apocynaceae) https://doi.org/10.26538/tjnpr/v1i4.4
Main Article Content
Abstract
Tabernaemontana pachysiphon Staph. (Apocynaceae) stem bark is used ethnomedicinally for the treatment of diabetes. This study determined the phytochemical constituents and evaluate the methanol stem bark extract for acute toxicity and hypoglycaemic activity in Wistar albino rats. Phytochemical analysis was done using standard methods. Acute toxicity was evaluated by administering 0.5, 1, 2 and 4 g/kg body weight of extract to rats. Diabetes was induced by administering a single dose of 50 mg/kg streptozotocin (i.p) and the hypoglycaemic effects of daily doses of 125, 500 and 1000 mg/kg extract, orally administered to fasted normal and diabetic rats for 14 days, were monitored at 1, 2, 4, 8 and 12 h, as well as on days 7 and 14. Phytochemical screening revealed the presence of glycosides, saponins, terpenoids, flavonoids and alkaloids. The extract at a dose of 4 g/kg, caused neither death nor any observable symptoms of toxicity after 24h and then, for 14 days. In non-diabetic rats, doses of 500 and 1000 mg/kg extract produced significant reductions (p < 0.05) in blood glucose at 8 h and 2 h, respectively. In diabetic rats, doses of 500 and 1000 mg/kg extract caused significant reductions (p < 0.05) at 4 h and 2 h, respectively, with maximum effect at 12 h. In both, the effect of the extract was found to be dosedependent. In conclusion, this study revealed that the methanol stem bark extract of T. bpachysiphon possessed hypoglycaemic effects, thus validating the ethnomedicinal claims of the plant.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Alberti KGMM, DeFronzo RA, Zimmet P. International textbook of diabetes mellitus. (2nd ed.). New York: J. Wiley; 1997.
International Diabetes Federation. IDF Diabetes Atlas, 7th ed.[Online]. 2015 [cited 2017 Aug 28]. Available from: http://www.diabetesatlas.org/resources/2015-atlas.html.
Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and
progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329:977-986.
UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352:837-853.
Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with noninsulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995; 28:103-117.
Leeuwenberg AJM, Kupicha FK. Apocynaceae. In: Launert E (Ed.). Flora Zambesiaca 7 (Part 2). London: Flora Zambesiaca Managing Committee; 1985. 395-498 p.
Burkhill HM. The useful plants of West Tropical Africa: vol. 1. Families A – D. (2nd ed.). Kew: Royal Botanical Gardens; 1985. 960 p.
Elia J. Tabernaemontana pachysiphon Stapf. In: Schmelzer GH, Gurib–Fakim A (Eds.). Prota II: Medicinal plants / Plantes medicinales. Netherlands: PROTA; 2006.
van Beek TA, Verpoorte R, Baerheim-Svendsen A, Leeuwenberg AJM, Bisset NG. Tabernaemontana L. (Apocynaceae): A review of its Taxonomy, Phytochemistry, Ethnobotany and Pharmacology. J Ethnopharmacol. 1984; 10: 1-156.
Uwumarongie OH, Onwukaeme DN, Obasuyi O. Antimicrobial activity of the methanolic leaf extract of Tabernaemontana pachysiphon Stapf. (Apocynaceae). J Nat Prod Med. 2007;11(2):23-25.
Uwumarongie HO, Onwukaeme DN, Bafor EE. Antiulcer effects and elements of Tabernaemontana pachysiphon stem bark. Nig J Pharm Res. 2008; 7(1):69-75.
Duru CM, Mbata TI. The antimicrobial activities and phytochemical screening of ethanolic leaf extracts of Hedranthera barteri hook and Tabernaemontana pachysiphon stapf. J Dev Bio & Tissue Eng. 2010; 2(1):1-4.
Uwumarongie HO, Onwukaeme DN. Pharmacognostic and toxicity evaluation of the stem bark of Tabernaemontana pachysiphon Stapf. (Apocynaceae). Nig J Pharm Res. 2011; 9(1):63-71.
Ambujam V, Ehindero AO, Fregene ER, Nwanze EAC, Parimoo P. Seed oil analysis of Tabernaemontana speciesindigenous to Nigeria. Nig J Pharm. 1981; 12:449-450.
Duru CM., Anyadoh-Nwadike SO, Okechukwu RI. Antimicrobial activity and Phytochemical analysis of aqueous and ethanolic extracts of the bark of Tabernaemontena pachysiphon Stapf. Sci J Pub Health 2015; 3(5-1):8-13.
Watt JM, Breyer-Brandwijk MG. The Medicinal and Poisonous plants of Southern and Eastern Africa. (2nd ed.). Edinburgh: E & S. Livingstone; 1962. 733-743 p.
Gill LS. Ethnomedical uses of plants in Nigeria. Benin City: Uniben press; 1992. 226 p.
Omino EA, Kokwaro JO. Ethnobotany of Apocynaceae species in Kenya. J Ethnopharmacol. 1993; 40 (3):167-180.
Harborne JB. Phytochemical Methods. (1st ed.). London: Chapman and Hall, Ltd.; 1973. p 49-188.
Sofowora A. Medicinal plants and Traditional Medicine in Africa. (3rd ed.). Ibadan: Spectrum Books Ltd.; 2008. 199-204p.
Miller, LC, Tainter, ML. Estimation of the ED50 and its errors by means of logarithmic-probit graph paper. Proc Soc Exp Biol Med. 1944; 57:261-264.
Igbe I, Osigwe C. Hypoglycaemic activity of aqueous extract of Pentaclethra macrophylla benth. (Fabaceae) stem bark in Streptozotocin-induced diabetic rats. J Pharm Bioresources. 2012; 9(1):39-44.
Igbe I, Omogbai EKI, Ozolua RI. Hypoglycemic activity of aqueous seed extract of Hunteria umbellata in normal and Streptozotocin induced diabetic rats. Pharm Biol. 2009; 47(10):1011-1016.
Evans WC. Trease and Evans Pharmacognosy. (16th ed.). Philadelphia: WB Saunders; 2009. 603 p.
Carini M, Adlini G, Furlanetto S, Stefani R, Facino RM. LC coupled to ion-trap MS for the rapid screening and detection of polyphenol antioxidants from Helichrysum stoechas. J Pharm Biomed Anal. 2001; 24:517-526.
Loomis TA. Essentials of Toxicology. (3rd ed.). Philadelphia: Lea and Feibiger; 1978. 198 p.
Weiss RB. Streptozotocin: A review of its pharmacology, efficacy and toxicity. Canc Treat Rep. 1982; 66: 427-438.
Abeeleh MA, Ismail ZB, Alzaben KR, Abu-Halaweh SA, AlEssa MK, Abuabeeleh J, Alsmady MM. Induction of diabetes mellitus in rats using intraperitoneal streptozotocin: A comparison between 2 strains of rats. Eur J Sci Res. 2009; 32(3):398-402.
Chatzigeorgiou A, Halapas A, Kalafatakis K, Kamper E. The use of animal models in the study of diabetes mellitus. In vivo. 2009; 23:245-258.
Rastogi AK, Ramesh C, Arvind KS. Screening of natural products for hypolipidaemic and hypoglycaemic activities. International workshop on medicinal plants, their bioactivity, screening and evaluation: Lucknow. 1997. 1-17 p.
Moller DE. New drug targets for type 2 diabetes and the metabolic syndrome. Nature. 2001; 414:821-827.
Rajasekar R, Manokaran K, Rajasekaran N, Duraisamy G, Kanakasabapathi D. Effect of Alpinia calcarata on glucose uptake in diabetic rats - an in-vivio and in- vitro model. J Diabetes Metab Disord. 2014; 13:33-44.
Kamalakkannan N, Prince PS. Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic Wistar rats. Basic Clin Pharmacol Toxicol. 2006; 98:97-103.
Kirana H, Jali MV, Srinivasan BP. The study of aqueous extract of Ficus religiosa Linn. on cytokine TNF-α in type 2 diabetic rats. Phcog Res. 2011; 3:30-34.
Miura T, Koike T, Ishida T. Antidiabetic activity of green tea (Thea sinensis L.) in genetically type 2 diabetic mice. J HealthSci. 2005; 51(6):708-710.
Ragavan B, Krishnakumari S. Antidiabetic effect of T. arjunabark extract in alloxan induced diabetic rats. Indian J Clin Biochem. 2006; 21(2):123-128